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Although osteoarthritis (OA) is deﬁned as a cartilage disease, synovitis involving
mononuclear cell inﬁltration and overexpression of proinﬂammatory mediators is common
in early and late OA. Calcium crystals deposition is thought to be a factor that likely
contributes to synovial inﬂammation. In recent years, signiﬁcant interest has emerged in
the beneﬁcial health effects attributed to the green tea polyphenols and in particular to
epigallocatechin-3-gallate (EGCG). It has been demonstrated that some of the actions of
EGCG are linked to its ability to interfere with cell membranes. The objective of this study
was to evaluate the inﬂuence of EGCG in some inﬂammatory aspects of OA and whether
EGCG is able to interfere with membrane organization. We assessed the effect of EGCG
on the production of proinﬂammatory cytokines and chemokines released by human
ﬁbroblast-like synoviocytes (FLS) and THP-1 cells stimulated with calcium pyrophosphate
(CPP) crystals in presence of methyl-β-cyclodextrin (MβCD), a cholesterol-removing agent
that disturbs lipid raft structures. The chemotactic effect of culture supernatants was also
evaluated. EGCG inhibited interleukin (IL)-1β, transforming growth factor beta, IL-8, and
chemokine (C–C motif) ligand 2 (CCL2) release by stimulated FLS and/or THP-1 cells in
a dose-dependent manner. Supernatants of CPP-stimulated cells induced the migration
of neutrophils and mononuclear cells which decreased in a dose-dependent manner in
the presence of EGCG. EGCG increased cell viability when added to THP-1 cells treated
with MβCD. Furthermore, MβCD enhanced the inﬂammatory response to CPP crystals
increasing IL-8 and CCL2 secretion which was inhibited by EGCG in a dose-dependent
manner. This study showed that EGCG is able to reduce the inﬂammatory response
induced by CPP crystals in vitro. The identiﬁcation of EGCG as dietary supplement capable
of affording protection or modulating the inﬂammatory response to CPP crystals may
have important implications in the prevention and treatment of OA and crystal-related
arthropathies.
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INTRODUCTION
Although osteoarthritis (OA) is deﬁned as a cartilage disease, syn-
ovitis involving mononuclear cell inﬁltration and overexpression
of proinﬂammatory mediators is common in early and late OA
(Benito et al., 2005; Punzi et al., 2005).
Calcium crystals deposition is thought to be a factor that likely
contributes to synovial membrane inﬂammation (Jaovisidha and
Rosenthal, 2002).
Calcium pyrophosphate (CPP) dihydrate crystals and basic
calcium phosphate crystals are often present in synovial ﬂuid
from patients with OA. They have been demonstrated in up to
60% of knee OA effusions (Gibilisco et al., 2009) with a preva-
lence of about 22% for CPP (Oliviero et al., 2012b), and in
100% of knee and hip cartilage of patients with end stage of
OA undergoing replacement (Fuerst et al., 2009). These crystals
have a still undeﬁned role in OA inﬂammation but, whether pri-
mary or secondary to tissue degeneration they may accelerate the
osteoarthritic process (Nalbant et al., 2003).
Green tea (Camellia sinensis) is one of the most commonly
consumed beverages in the world and is a rich source of
polyphenols known as catechins including epigallocatechin-3-
gallate (EGCG) which constitutes up to 63% of total catechins
(Manning and Roberts, 2003).
Epigallocatechin-3-gallate has been shown to exhibit protective
effects on a number of clinical conditions, including stroke and
cerebral hemorrhage, cardiovascular and liver diseases, bacte-
rial infections, cancer, atherosclerosis, and autoimmune diseases
(Mak, 2012). Extensive studies in the past decade have also veriﬁed
the cartilage-preserving and chondroprotective action of EGCG
(Ahmed et al., 2006; Morinobu et al., 2008).
It has been demonstrated that some of the actions of EGCG are
linked to its binding to the cell surface and the interaction with
the plasma membrane microdomains referred to as “lipid rafts”
(Duhon et al., 2010). Furthermore the antiproliferative effect and
antioxidant capacity of EGCG seem to be associated to its ability to
modify lipid bilayers, the membrane ﬂuidity and to its stabilizing
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effect on the cell membranes (Tsuchiya et al., 2008; Margina et al.,
2012).
The objective of this study was to evaluate the inﬂuence of
EGCG in some inﬂammatory aspects of OA and whether EGCG
is able to interfere with lipid membrane organization.
To this aim, we assessed the effect of EGCG on the produc-
tion of proinﬂammatory cytokines and chemokines released by
human ﬁbroblast-like synoviocytes (FLS) and THP-1 cells stimu-
lated with CPP crystals in the presence of methyl-β-cyclodextrin
(MβCD), a cholesterol-removing agent that disturbs raft
structure.
MATERIALS AND METHODS
FLS ISOLATION AND TREATMENT
Synovial tissue specimens were obtained from OA patients
undergoing surgical joint replacement. FLS were isolated from tis-
sue explants, as previous described (Scanu et al., 2007) and grown
in Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing 10%
heat-inactivated fetal calf serum (FCS), 50 μg/ml streptomycin,
50 U/ml penicillin, and 2 mmol/l glutamine. All experiments were
carried out with passage 4 through 8. FLS were CD90+, CD55+,
and were positive for prolyl-4-hydroxylase, as demonstrated by
immunocytochemical staining with speciﬁc antibodies (Chemi-
con International). FLS were seeded in 96-well culture plates at a
density of 1 × 104 cells/well. Cells were allowed to adhere for 24 h,
and then the medium was exchanged for a medium supplemented
with 2% FCS,CPP crystals 0.025 mg/ml and EGCG 1, 5, or 10 μM.
A mother solution of EGCG 10 mM was prepared in phosphate
buffered saline (PBS) solution and diluted in the medium at the
time of experiment while crystals were suspended directly in the
medium.
THP-1 CELL CULTURE AND TREATMENT
The human leukemic monocytic cell line THP-1, was obtained
from theAmericanTypeCultureCollection (Rockville,MD,USA).
Cells were cultured in Roswell Park Memorial Institute (RPMI)
1640 medium supplemented with 10% FCS. In some experiments,
cells were primed for 3 h with phorbol 12-myristate 13-acetate
(PMA; Sigma-Aldrich) at 300 ng/ml and reincubated overnight
with fresh medium supplemented with 10% FCS. Cells were
then treated with CPP (ﬁnal concentration 0.025 mg/ml; Invivo-
Gen) for 24 h in presence or absence of EGCG (10, 50 μM)
and 2% FCS. Cells incubated with medium alone served as
controls.
In some experiments, before stimulation with crystals FLS and
THP-1 were pretreated for 1 h with EGCG at the indicated con-
centrations or for 45 min with 10 mM MβCD (Sigma-Aldrich)
prepared from a 500 ng/ml PBS mother solution.
To exclude a contribution of endotoxin contamination,
10 μg/ml of polymyxin B (Sigma-Aldrich) was included in all
the stimulation assays.
CYTOKINE DETERMINATION
The levels of interleukin (IL)-1β, IL-8, chemokine (C–C motif)
ligand 2 (CCL2) and transforming growth factor beta (TGFβ)
were determined in the culture supernatants by enzyme-linked
immunosorbent assay (eBioscience).
MTT ASSAY
To measure cell viability and proliferation the colorimetric MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
mitochondrial activity assay (Chemicon) was used.
Cells were cultured in a 96-well plate at 37◦C, and exposed to
varying concentrations of crystals, EGCG for 24 h. Cells treated
withmediumonly served as a negative control group. After remov-
ing the supernatant cells were incubatedwith theMTT solution for
4 h and the resultant formazan crystals were dissolved in dimethyl
sulfoxide and the absorbance intensity measured at 570 nm. The
cell viability (%) was expressed as a percentage relative to the
untreated control cells.
CHEMOTAXIS ASSAY
After inform consent, mononuclear and polymorphonuclear
(PMN) cells were isolated from peripheral blood from healthy vol-
unteers by density gradient centrifugation with Histopaque 1077
(Sigma-Aldrich).
The chemotactic effect of culture supernatants of cells exposed
to CPP crystals and EGCG was assessed by using a 48-well modi-
ﬁed Boyden chamber (AC48; NeuroProbe) as previously described
(Scanu et al., 2010). In brief, 28 μl aliquots of culture supernatants
were loaded in the bottom chamber, and mononuclear or PMN
cells were added to the top chamber. RPMI 1640 was used as a
negative control, while 10 ng/ml CCL2 or IL-8 (RayBiotech) were
used as a positive control. A polyvinylpyrrolidone-free polycar-
bonate 8-mm membrane with 5-μm or 3-μm pores, pretreated
with 10 μg/ml ﬁbronectin, was placed between the chambers.
Fifty-microliter aliquots of mononuclear cells (1 × 106 cells/ml)
or PMN cells (3 × 106 cells/ml) resuspended in RPMI 1640 were
added to the top wells.
Chambers were incubated at 37◦C with 5% CO2 for 2 h. The
membrane was then removed, washed with PBS on the upper side,
ﬁxed, and stained with DiffQuik (Baxter Scientiﬁc). Cells were
counted microscopically at ×1,000 magniﬁcation and expressed
as total number of cells per membrane. All assays were performed
in duplicate.
STATISTICS
Results are presented as mean ± SD of n experiments per-
formed in triplicate. Statistical differences were determined by
non-parametric Mann–Whitney test, taking a p-value <0.05 as
signiﬁcant.
RESULTS
EGCG INHIBITS CPP CRYSTAL-INDUCED CYTOKINE AND CHEMOKINE
PRODUCTION IN FLS AND THP-1 CELLS
In the absence of stimulus, FLS released low but signiﬁcant levels
of both IL-8 and CCL2 in culture supernatants (Figures 1A,B).
Calcium pyrophosphate crystals stimulation of FLS induced an
increased release of IL-8 and CCL2 over the basal concentration.
This effect was suppressed by EGCG which inhibited chemokine
levels in a dose-dependent manner. EGCG slightly affected also
the basal release of these chemokines (Figures 1A,B).
Supernatants of CPP-stimulated cells induced the migra-
tion of PMN cells (about sixfold over the control) and
mononuclear cells (about fourfold over the control) which
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FIGURE 1 | Effect of EGCG on IL-8 and CCL2 production by FLS
stimulated with CPP crystals (A,B). Effect of culture supernatants on the
migration of PMN and mononuclear cells (C,D). The values are expressed as
the mean ± SD; CPP 0.025 mg/ml; EGCG expressed as micromolar. Data are
representative of one of three independent experiments ± SD of three
replicates. *p < 0.05, **p < 0.01 vs control; ◦p < 0.05 vs CPP.
decreased in a dose-dependent manner in the presence of EGCG,
with the basal migration effect restored with EGCG 5 μM
(Figures 1C,D).
To evaluatewhether the effect of EGCGwasmediatedby adirect
action on cell, FLS and THP-1 cells were pretreated with EGCG
and washed before crystal stimulation. EGCG at 1, 5, and 10 μM
reduced chemokine levels on culture medium also in pretreated
cells (Figure 2).
As CPP crystals alone are not able to induce IL-1β and TGFβ
production, THP-1 cells were primed with PMA 300 ng/ml for
3 h, followed by an overnight medium renewal and crystal stimu-
lation. THP-1 cells showed a marked reduction in IL-1β and TGFβ
production after EGCG treatment (Figure 3).
Epigallocatechin-3-gallate alone showed a trend toward reduc-
tion of IL-8, CCL2, IL-1β, and TGFβ release from non-treated
cell. As regards the overall effect of EGCG, it has been observed
by others that EGCG added to DMEM underwent rapid oxidation
to generate H2O2 (Long and Halliwell, 2009) but that in presence
of pyruvate in the medium (ﬁnal concentration 1 mM) much less
H2O2 was detected. In particular, for concentrations of EGCG up
to 100 μM, almost no H2O2 was detected at all. In our exper-
iments, we used EGCG at concentration <100 μM and we can
therefore exclude that the effect of EGCG against CPP stimulation
is an artifact due to oxidation products.
EGCG INCREASES CELL VIABILITY
To assess whether the effect of EGCG was associated with
modiﬁcations onmembraneorganizationTHP-1 cellswere treated
45 min with 10 mM MβCD before CPP crystal stimulation and
cell activity was examined.
The results demonstrated that EGCGat 10 and50μMincreased
cell viability in THP-1 cells both untreated and treated with
different concentrations of MβCD (Figure 4).
The treatment of cells with MβCD signiﬁcantly increased the
release of IL-8 and CCL2 into the medium with respect to con-
trol conditions. Furthermore the inhibitory action of EGCG
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FIGURE 2 | Effect of 1 h pretreatment of cells with EGCG before CPP
crystal stimulation on IL-8 production. Results from FLS (A) andTHP-1
(B) cells. The values are expressed as the mean ± SD; CPP 0.025 mg/ml;
EGCG expressed as micromolar. Data are representative of one of three
independent experiments ± SD of three replicates. *p < 0.05, **p < 0.01
vs control; ◦p < 0.05 vs CPP.
on MβCD-enhanced inﬂammatory response to CPP crystals
(Figure 5) suggests that the effect of EGCG is independent from
lipid membrane organization.
DISCUSSION
This study showed that EGCG, the main catechin of green tea, is
able to reduce cytokine release in FLS and THP-1 cells. We have
found a basal release of CCL2 and IL-8 in culture supernatants of
both untreated FLS and THP-1 cells which enhanced in presence
of CPP crystals. EGCG slightly affected the basal release of these
chemokines but reduced CPP crystal-induced inﬂammation into
a baseline level with an appropriate dosage.
FIGURE 3 | IL-1β andTGFβ levels after a pretreatment of 3 h ofTHP-1
cells with PMA and stimulation with CPP crystals.The values are
expressed as the mean ± SD; CPP 0.025 mg/ml; PMA 300 ng/ml; EGCG
expressed as micromolar. Data are representative of one of three
independent experiments ± SD of three replicates. *p < 0.05 vs control;
◦p < 0.05, ◦◦p < 0.01 vs CPP.
While calcium crystals in OA are associated with a more severe
disease, in pseudogout they can cause powerful inﬂammatory
reactions comparable to those triggered by monosodium urate
crystals. The concentrations of CPP crystals used in this study
are similar to those observed in synovial ﬂuids collected dur-
ing intercritical attacks of pseudogout and therefore reproduce
a pathophysiological condition (Swan et al., 1995).
It is known that CPP crystals activate speciﬁc signaling path-
way leading to the production of inﬂammatory cytokines and
chemokines in the synovial compartment (Busso and Ea, 2012).
Activated resident FLS are known to be central mediators
of crystal-induced inﬂammation through the production of
cytokines and chemokines that mediate the recruitment and
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FIGURE 4 | Effect of EGCG on cell damage induced by MβCD. Cells
were preincubated 45 min with MβCD at the indicated concentrations and
treated with EGCG. Cell activity was then evaluated after 24 h. The values
are expressed as the mean ± SD; MβCD expressed as millimolar; EGCG
expressed as micromolar. Data are representative of one of three
independent experiments ± SD of three replicates. *p < 0.05 vs EGCG 0.
activation of leukocytes. We have previously demonstrated the
presence of intracellular stores of CCL2 in FLS which might par-
ticipate in the rapid response of joint cells to crystals, attracting
monocytes/macrophages into the tissue in an attempt to eliminate
the inﬂammatory agent rapidly (Scanu et al., 2010).
Through inﬂammasome assembly, CPP crystals are able to
activate caspase-1 and subsequently the release of IL-1β in the
extracellular space (Gombault et al., 2012). But a second stim-
ulus is needed to prime cells to generate IL-1β in vivo. It has
been hypothesized that serum protein (Oliviero et al., 2012a) and
Toll-like receptor ligands such as free fatty acids (Mylona et al.,
2012) synergize with crystals on IL-1β induction. In this study,
we used the protein kinase C activator PMA which inﬂuences
cell differentiation and stimulate monocyte functions including
phagocytosis.
After cell priming, we observed an increase of IL-1β and TGFβ
production by CPP crystals which was inhibited by EGCG. TGFβ
is involved in crystal formation through the generation of extracel-
lular inorganic pyrophosphate (Olmez et al., 1994). Its expression
is strongly associated to hypertrophic chondrocytes around cal-
cium crystal deposits and its action is antagonized by IL-1β (Lotz
et al., 1995). We had previously found increased TGFβ level in OA
synovial ﬂuid positive to CPP crystals with respect to OA synovial
ﬂuid without crystals (Punzi et al., 2003) but little is known on the
direct effect of CPP on TGFβ production and if the latter may be
linked on IL-1β release.
Along with the anti-inﬂammatory effect of EGCG on cytokine
and chemokine concentrations, we also observed an anti-
chemokinetic effect on human neutrophil and mononuclear cells
induced by culture supernatants of cells exposed to crystals and
EGCG.
As cell migration play a signiﬁcant role on the ampliﬁcation
of the inﬂammatory response to pathogenetic crystals in terms
of synovial cell and endothelial activation (Liu-Bryan and Lioté,
2005), this also represents an important results of this work.
Another important ﬁnding is that the anti-inﬂammatory capac-
ity of EGCG could be due to its protective and direct effect on the
cell membranes.
FIGURE 5 | Effect of EGCG on IL-8 and CCL2 production byTHP-1
stimulated with CPP crystals after a pretreatment of 45 min with
MβCD.The values are expressed as the mean ± SD; CPP 0.025 mg/ml;
MβCD expressed as millimolar; EGCG expressed as micromolar. Data are
representative of one of three independent experiments ± SD of three
replicates. *p < 0.05, **p < 0.01 vs control; ◦p < 0.05, ◦◦p < 0.01 vs CPP.
It has been observed that green tea catechins have a stabilizing
effect on the cell membranes reducing ﬂuidity of lipid bilay-
ers (Tsuchiya, 1999) and increasing membrane anisotropy and
polarization (Margina et al., 2012).
Although our results does not elucidate the exact mechanism
of action of EGCG, we have shown that the pretreatment of cells
with EGCG is also effective in inhibiting chemokine release. Fur-
thermore, EGCG was able to increase cell viability also after the
destruction of speciﬁc cell membrane microdomains by MβCD.
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However, our results showed that MβCD treatment does not
affect EGCG effect on the inﬂammatory response to CPP crystals
suggesting an independent role of EGCG from lipid rafts.
It has been demonstrated that only a small percentage of the
ingested catechins appears in the blood. After drinking the equiv-
alent of ∼2 cups of tea, the mean peak plasma EGCG level has
been shown to be <1 μM (Lee et al., 2002). Although these val-
ues are lower than those used in in vitro experiments with EGCG,
an effective concentration of this catechin could be achieved by
dietary supplementation.
In conclusion, the use of EGCG in our in vitro model of CPP
crystal-induced inﬂammation lead to a signiﬁcant inhibition of
the inﬂammatory response.
Osteoarthritis, besides CPP crystal-related arthropathies, con-
tinue to be difﬁcult disorders to treat, as there is no cure
as such and current treatments focus mainly on relieving
pain and maintaining joint function. None of the therapeu-
tic approaches appear to be able to spare cartilage from the
ongoing degenerative process of OA and from synovitis in pseu-
dogout (Dingle, 1991; Schlesinger et al., 2009). In this context
the identiﬁcation of EGCG as substance capable of affording
protection or modulating the inﬂammatory response to CPP
crystals may have important therapeutic implications. Further
studies elucidating the role of EGCG dietary supplementation are
needed.
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